SlideShare a Scribd company logo
1 of 19
Presented By – Ms. Shikha Jain
Date –
Venue -
Presentation on
D-U-N-S® Number & FEI Number
BACKGROUND
 Self identification of generic drug facilities,
Sites and organizations:
 In GDUFA 2012, FDA’s requirement of submission
of Self identification information by human generic
drug facilities, Sites and organizations is listed.
 On July 9, 2012 GDUFA was designed;
To speed the delivery of safe and effective
generic drugs to the public and,
To reduce costs to industry.
BACKGROUND
 FDA is establishing a new system for electronic
self-identification of generic industry facilities and
organization.
 Therefore, entities that are required to register
and list (under section 510 of Federal Food, drug
And cosmetic Act or section 351 of the Public
Health Service Act) are required to Self-identify
with GDUFA.
 Once self identification procedure has been
completed, FDA will determine facility fees that is
required to be paid annually.
Who is required to Self Identify
1
• Facilities that manufacture or intend to manufacture,
human generic drug APIs or FDFs or both
2
• Sites and organizations involved in packaging and
labeling of FDF into primary container / closure system
3
• Sites involved in re-packaging and labeling of FDF into
primary container / closure system of different size
4
• Bioequivalence (BE) / bioavailability (BA) sites
Self
identification
D-U-N-S®
Number
FEI Number
Information required for
Self identification
background
 The federal government requires that all
applicants for federal grants and cooperative
agreements have a D-U-N-S® Number.
 The federal government will use D-U-N-S®
Number to identify related organizations that are
receiving funding under grants and cooperative
agreements
INTRODUCTION
 In 1962, Dun & Bradstreet established business
identification database in the form of D-U-N-S®
Number: 9 digit identification number
D - Data
U - Universal
N - Numbering
S - System
D-U-N-S® may be issued with or without dashes for
readability: XX-XXX-XXXX OR XXXXXXXXX
INTRODUCTION
 D-U-N-S® Number is D&B’s copyrighted
proprietary means identifying business entities
on a location specific basis.
Specific for each site.
Each distinct physical location of an entity (i.e.
branch, division and headquarter) would be
assigned a different D-U-N-S® Number.
FDA’s recommendation
 FDA will require D-U-N-S® Number for both the
facility and the registrant owner of the facility if both
are at different locations.
 D-U-N-S® Number is required to uniquely identify
registrant owner and each physical location of the
business entity of the registrant.
 D-U-N-S® Number serves as useful resource for
FDA in identifying and verifying certain business
information submitted by a user.
Number
Verification
and
existence of
operations
Demographic
information
Corporate
relationship
s
Compatibility
with National
Business
registries -
USFDA &
MHRA
Keep
accurate
business
data
What do I need to get my D-U-N-S®
Number
D-U-N-S
®
Number
Legal
Name
Head-
quarters
name
DBA or name
by which
business is
recognized
Address,
City, State
and ZIP
code E-mail
Address
Telephone
number
No. Of
employees
at physical
location
FEI number
 FEI number – a unique identifier designated by
FDA to assign, monitor and track inspections
of regulated firms.
F – Facility
E – Establishment
I – Identifier
FEI number
 FDA assigns only one FEI number to separate
buildings:
If they are in close proximity.
If the activities conducted in each building are
closely related to the same business enterprise,
Are under the supervision of same local
management
Are capable of being inspected by FDA during a
single inspection.
How to obtain FEI number
Generic drug facilities,
Sites & organizations
Previously registered
with FDA
Existing
FEI No.
Not Previously registered
with FDA
Application for new FEI
no.
Email request to FDA
GDUFA FEI Request
in the subject line
Provide subsequent
information
What do I need to get my FEI
Number
FEI
Number
Legal Name
Type of
operation :
Manufacturer ,
Labs etc
Address,
City, ZIP
code, State,
Country
E-mail
Address &
Telephone
number
Type of
Industry :
Drugs
Size of the
firm
Penalty for failing to Self identify
All FDF & API
manufactured
at the facility
will be
deemed
misbranded
It is a
violation of
Federal Law
to ship
misbranded
product in
interstate
commerce or
to import
them into
United States
Such
Violations are
responsible
for Seizures
of the
misbranded
product
Misbranded
product are
subjected to
being denied
entry into
United
States.
D-U-N-S & FEI Number

More Related Content

What's hot

Understanding 21 cfr part 11
Understanding 21 cfr part 11Understanding 21 cfr part 11
Understanding 21 cfr part 11
complianceonline123
 
The Electronic Regulatory Submission
The Electronic Regulatory SubmissionThe Electronic Regulatory Submission
The Electronic Regulatory Submission
Dr.RAJEEV KASHYAP
 

What's hot (20)

21 cfr part 11 basic
21 cfr part 11 basic21 cfr part 11 basic
21 cfr part 11 basic
 
ANDA filing
ANDA filingANDA filing
ANDA filing
 
US DMF v/s European DMF
US DMF v/s European DMFUS DMF v/s European DMF
US DMF v/s European DMF
 
21 CFR Part 11.pptx
21 CFR Part 11.pptx21 CFR Part 11.pptx
21 CFR Part 11.pptx
 
21 CFR part 11 Overview
21 CFR part 11 Overview21 CFR part 11 Overview
21 CFR part 11 Overview
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
 
DRUG MASTER FILE AND GLOBAL REGULATORY REQUIREMENTS
DRUG MASTER FILE AND GLOBAL REGULATORY REQUIREMENTSDRUG MASTER FILE AND GLOBAL REGULATORY REQUIREMENTS
DRUG MASTER FILE AND GLOBAL REGULATORY REQUIREMENTS
 
21 CFR PART 11
21 CFR PART 1121 CFR PART 11
21 CFR PART 11
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
 
21 CFR PART 50.pptx
21 CFR PART 50.pptx21 CFR PART 50.pptx
21 CFR PART 50.pptx
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
CTD and ECTD by Akshay Trivedi
CTD and ECTD by Akshay TrivediCTD and ECTD by Akshay Trivedi
CTD and ECTD by Akshay Trivedi
 
21 code of federal regulation
21 code of federal regulation21 code of federal regulation
21 code of federal regulation
 
Understanding 21 cfr part 11
Understanding 21 cfr part 11Understanding 21 cfr part 11
Understanding 21 cfr part 11
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairs
 
The Electronic Regulatory Submission
The Electronic Regulatory SubmissionThe Electronic Regulatory Submission
The Electronic Regulatory Submission
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letter
 

Similar to D-U-N-S & FEI Number

Similar to D-U-N-S & FEI Number (20)

Self identification
Self identificationSelf identification
Self identification
 
Get Ready To Sell To The Government
Get Ready To Sell To The GovernmentGet Ready To Sell To The Government
Get Ready To Sell To The Government
 
Doing Business with the Federal Government
Doing Business with the Federal GovernmentDoing Business with the Federal Government
Doing Business with the Federal Government
 
ASU SBTDC Steps to Doing Business with the Government
ASU SBTDC Steps to Doing Business with the GovernmentASU SBTDC Steps to Doing Business with the Government
ASU SBTDC Steps to Doing Business with the Government
 
FATCA/CRS Preexisting Entity Account Review
FATCA/CRS Preexisting Entity Account ReviewFATCA/CRS Preexisting Entity Account Review
FATCA/CRS Preexisting Entity Account Review
 
How your vendor master file is critical to governance, risk management and co...
How your vendor master file is critical to governance, risk management and co...How your vendor master file is critical to governance, risk management and co...
How your vendor master file is critical to governance, risk management and co...
 
382 Studies
382 Studies382 Studies
382 Studies
 
USWCC | Review of the Proposed Regulations for the Women's Federal Procuremen...
USWCC | Review of the Proposed Regulations for the Women's Federal Procuremen...USWCC | Review of the Proposed Regulations for the Women's Federal Procuremen...
USWCC | Review of the Proposed Regulations for the Women's Federal Procuremen...
 
Rightside Investor Presentation – July 2014
Rightside Investor Presentation – July 2014Rightside Investor Presentation – July 2014
Rightside Investor Presentation – July 2014
 
FATCA Software Evaluative Case Studies
FATCA Software Evaluative Case StudiesFATCA Software Evaluative Case Studies
FATCA Software Evaluative Case Studies
 
How to-register-a-partnership-business
How to-register-a-partnership-businessHow to-register-a-partnership-business
How to-register-a-partnership-business
 
Key Differences between Medical Device User Fees and Establishment Registrati...
Key Differences between Medical Device User Fees and Establishment Registrati...Key Differences between Medical Device User Fees and Establishment Registrati...
Key Differences between Medical Device User Fees and Establishment Registrati...
 
Doing Business With The Department of Defense (DOD)
Doing Business With The Department of Defense (DOD)Doing Business With The Department of Defense (DOD)
Doing Business With The Department of Defense (DOD)
 
Covered Entity Presentation Regarding Business Associates[1]
Covered Entity Presentation Regarding Business Associates[1]Covered Entity Presentation Regarding Business Associates[1]
Covered Entity Presentation Regarding Business Associates[1]
 
Draganfly Deck January 2022
Draganfly Deck January 2022Draganfly Deck January 2022
Draganfly Deck January 2022
 
Denied party screening 2016 webinar final
Denied party screening 2016 webinar finalDenied party screening 2016 webinar final
Denied party screening 2016 webinar final
 
Denied party screening 2016 webinar final
Denied party screening 2016 webinar finalDenied party screening 2016 webinar final
Denied party screening 2016 webinar final
 
Astrid Illum: Scales of Anubis - Superweek 2020
Astrid Illum: Scales of Anubis - Superweek 2020Astrid Illum: Scales of Anubis - Superweek 2020
Astrid Illum: Scales of Anubis - Superweek 2020
 
v20200820 PARXTC Export Trading Company Membership Services Options and Corpo...
v20200820 PARXTC Export Trading Company Membership Services Options and Corpo...v20200820 PARXTC Export Trading Company Membership Services Options and Corpo...
v20200820 PARXTC Export Trading Company Membership Services Options and Corpo...
 
Valuation of Intangibles
Valuation of IntangiblesValuation of Intangibles
Valuation of Intangibles
 

D-U-N-S & FEI Number

  • 1. Presented By – Ms. Shikha Jain Date – Venue - Presentation on D-U-N-S® Number & FEI Number
  • 2. BACKGROUND  Self identification of generic drug facilities, Sites and organizations:  In GDUFA 2012, FDA’s requirement of submission of Self identification information by human generic drug facilities, Sites and organizations is listed.  On July 9, 2012 GDUFA was designed; To speed the delivery of safe and effective generic drugs to the public and, To reduce costs to industry.
  • 3. BACKGROUND  FDA is establishing a new system for electronic self-identification of generic industry facilities and organization.  Therefore, entities that are required to register and list (under section 510 of Federal Food, drug And cosmetic Act or section 351 of the Public Health Service Act) are required to Self-identify with GDUFA.  Once self identification procedure has been completed, FDA will determine facility fees that is required to be paid annually.
  • 4. Who is required to Self Identify 1 • Facilities that manufacture or intend to manufacture, human generic drug APIs or FDFs or both 2 • Sites and organizations involved in packaging and labeling of FDF into primary container / closure system 3 • Sites involved in re-packaging and labeling of FDF into primary container / closure system of different size 4 • Bioequivalence (BE) / bioavailability (BA) sites
  • 6.
  • 7. background  The federal government requires that all applicants for federal grants and cooperative agreements have a D-U-N-S® Number.  The federal government will use D-U-N-S® Number to identify related organizations that are receiving funding under grants and cooperative agreements
  • 8. INTRODUCTION  In 1962, Dun & Bradstreet established business identification database in the form of D-U-N-S® Number: 9 digit identification number D - Data U - Universal N - Numbering S - System D-U-N-S® may be issued with or without dashes for readability: XX-XXX-XXXX OR XXXXXXXXX
  • 9. INTRODUCTION  D-U-N-S® Number is D&B’s copyrighted proprietary means identifying business entities on a location specific basis. Specific for each site. Each distinct physical location of an entity (i.e. branch, division and headquarter) would be assigned a different D-U-N-S® Number.
  • 10. FDA’s recommendation  FDA will require D-U-N-S® Number for both the facility and the registrant owner of the facility if both are at different locations.  D-U-N-S® Number is required to uniquely identify registrant owner and each physical location of the business entity of the registrant.  D-U-N-S® Number serves as useful resource for FDA in identifying and verifying certain business information submitted by a user.
  • 12. What do I need to get my D-U-N-S® Number D-U-N-S ® Number Legal Name Head- quarters name DBA or name by which business is recognized Address, City, State and ZIP code E-mail Address Telephone number No. Of employees at physical location
  • 13.
  • 14. FEI number  FEI number – a unique identifier designated by FDA to assign, monitor and track inspections of regulated firms. F – Facility E – Establishment I – Identifier
  • 15. FEI number  FDA assigns only one FEI number to separate buildings: If they are in close proximity. If the activities conducted in each building are closely related to the same business enterprise, Are under the supervision of same local management Are capable of being inspected by FDA during a single inspection.
  • 16. How to obtain FEI number Generic drug facilities, Sites & organizations Previously registered with FDA Existing FEI No. Not Previously registered with FDA Application for new FEI no. Email request to FDA GDUFA FEI Request in the subject line Provide subsequent information
  • 17. What do I need to get my FEI Number FEI Number Legal Name Type of operation : Manufacturer , Labs etc Address, City, ZIP code, State, Country E-mail Address & Telephone number Type of Industry : Drugs Size of the firm
  • 18. Penalty for failing to Self identify All FDF & API manufactured at the facility will be deemed misbranded It is a violation of Federal Law to ship misbranded product in interstate commerce or to import them into United States Such Violations are responsible for Seizures of the misbranded product Misbranded product are subjected to being denied entry into United States.